Matches in DBpedia 2016-04 for { ?s ?p "Repoxygen is the tradename for a type of gene therapy that induces controlled release of erythropoietin (EPO) in response to low oxygen concentration. It has been developed by Oxford Biomedica to treat anaemia. It has been developed in mice, is still in preclinical development and has not been extensively tested in humans.It is constructed as a viral gene delivery vector carrying the human EPO gene under the control of a so-called "hypoxia control element" (“HRE”)."@en }
Showing triples 1 to 1 of
1
with 100 triples per page.
- Q113943 comment "Repoxygen is the tradename for a type of gene therapy that induces controlled release of erythropoietin (EPO) in response to low oxygen concentration. It has been developed by Oxford Biomedica to treat anaemia. It has been developed in mice, is still in preclinical development and has not been extensively tested in humans.It is constructed as a viral gene delivery vector carrying the human EPO gene under the control of a so-called "hypoxia control element" (“HRE”).".